Wikisage, the free encyclopedia of the second generation, is digital heritage
Sjögren syndrome: Difference between revisions
Jump to navigation
Jump to search
m (ref) |
m (hide) |
||
| Line 4: | Line 4: | ||
It is a chronic and progressive multisystem autoimmune disease typically managed by rheumatologists. <ref>[https://www.ncbi.nlm.nih.gov/pubmed/28283891 The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis]</ref> | It is a chronic and progressive multisystem autoimmune disease typically managed by rheumatologists. <ref>[https://www.ncbi.nlm.nih.gov/pubmed/28283891 The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis]</ref> | ||
==Links== | |||
[http://www.tandfonline.com/doi/abs/10.1080/08916934.2017.1280027?journalCode=iaut20 Inflammation in Sjögren's syndrome: Cause or consequence?] | |||
{{Wikidata|Q335555}} | {{Wikidata|Q335555}} | ||
Revision as of 13:43, 12 March 2017
-
Karcher/PP(c)
The eponymous Sjögren syndrome is a keratoconjuntivitis sicca xerosftalmia[1] It is a chronic and progressive multisystem autoimmune disease typically managed by rheumatologists. [2]
Links
Inflammation in Sjögren's syndrome: Cause or consequence?
- ↑ dictionary of medical eponyms Ediciones Roche Basle, Switzerland, p 495
- ↑ The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis